Patients should be advised to refrain from scratching to avoid secondary lesions and reduce the risk of hyperpigmentation. Patients should be asked to follow up with their clinicians when their symptoms are uncontrollable and bothersome. Patients should be reassured regarding the prognosis and the fetal risks involved. These patients should also be advised to avoid estrogen-containing oral contraceptives or use them in the lowest doses possible.